Yi‐Hsin Weng

1.5k citations

33 papers · 1.0k indexed · h-index 18

Neurology top 2%
- Parkinson's Disease Mechanisms and Treatments 21
- Neurological diseases and metabolism 9
- Neurological disorders and treatments 6
Neurology top 2%
- Parkinson's Disease Mechanisms and Treatments 21
- Neurological diseases and metabolism 9
- Neurological disorders and treatments 6
Cellular and Molecular Neuroscience top 5%
- Genetic Neurodegenerative Diseases 7
- Nuclear Receptors and Signaling 7
Clinical Biochemistry top 10%
Physiology
Molecular Biology
- Ubiquitin and proteasome pathways 4
- Mitochondrial Function and Pathology 3
- RNA regulation and disease 3

Co-authors: Tu‐Hsueh Yeh Chin-Song Lu Hung‐Li Wang An-Hsun Chou Rou-Shayn Chen Yah‐Huei Wu‐Chou Hsiu‐Chen Chang Szu‐Chia Lai
Cited by: Neurology Cellular and Molecular Neuroscience
Journals: The Journal of Physiology (1 paper)International Journal of Molecular Sciences (1 paper)Biochemical Pharmacology (1 paper)
Partner nations: Taiwan Netherlands United Kingdom

In The Last Decade

Yi‐Hsin Weng

32 papers receiving 987 citations

Peers

Countries citing papers authored by Yi‐Hsin Weng

Since Specialization

Citations

This map shows the geographic impact of Yi‐Hsin Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐Hsin Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐Hsin Weng more than expected).

Fields of papers citing papers by Yi‐Hsin Weng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi‐Hsin Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐Hsin Weng. The network helps show where Yi‐Hsin Weng may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yi‐Hsin Weng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yi‐Hsin Weng Line = papers co-authored together Yi‐Hsin Weng links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Alda-1, an activator of ALDH2, ameliorates Achilles tendinopathy in cellular and mouse models Biochemical Pharmacology ·Yu-Chuan Liu,Hung‐Li Wang,Ying‐Zu Huang,Yi‐Hsin Weng,Rou-Shayn Chen,Wen‐Chung Tsai,Tu‐Hsueh Yeh,Chin-Song Lu,Ying‐Ling Chen,Yan-Wei Lin,Yu-Jie Chen,Chia-Chen Hsu,Chi-Han Chiu,Ching‐Chi Chiu,(unknown),(unknown)	2020	23
2	Generation of induced pluripotent stem cells from a young-onset Parkinson's disease patient carrying the compound heterozygous PLA2G6 p.D331Y/p.M358IfsX mutations Stem Cell Research ·Ching‐Chi Chiu,Hung‐Li Wang,Yi‐Hsin Weng,Rou-Shayn Chen,Chiung‐Mei Chen,Tu‐Hsueh Yeh,Chin-Song Lu,Yu-Jie Chen,Yu-Chuan Liu,Ying‐Zu Huang,Kuo‐Hsuan Chang	2019	3
3	PARK14 (D331Y) PLA2G6 Causes Early-Onset Degeneration of Substantia Nigra Dopaminergic Neurons by Inducing Mitochondrial Dysfunction, ER Stress, Mitophagy Impairment and Transcriptional Dysregulation in a Knockin Mouse Model Molecular Neurobiology ·Ching‐Chi Chiu,Chin-Song Lu,Yi‐Hsin Weng,Ying‐Ling Chen,Ying‐Zu Huang,Rou-Shayn Chen,Yi‐Chuan Cheng,Yin-Cheng Huang,Yu-Chuan Liu,Szu‐Chia Lai,Kun-Jun Lin,Yan-Wei Lin,Yu-Jie Chen,Chao-Lang Chen,Tu‐Hsueh Yeh,Hung‐Li Wang	2018	40
4	(R1441C) LRRK2 induces the degeneration of SN dopaminergic neurons and alters the expression of genes regulating neuronal survival in a transgenic mouse model Experimental Neurology ·Yi‐Hsin Weng,Chuyu Chen,Kun-Jun Lin,Ying‐Ling Chen,Tu‐Hsueh Yeh,Ing‐Tsung Hsiao,Ing-Jou Chen,Chin-Song Lu,Hung‐Li Wang	2015	26
5	(G2019S) LRRK2 causes early-phase dysfunction of SNpc dopaminergic neurons and impairment of corticostriatal long-term depression in the PD transgenic mouse Neurobiology of Disease ·Jun-Shiao Chou,Chuyu Chen,Ying‐Ling Chen,Yi‐Hsin Weng,Tu‐Hsueh Yeh,Chin-Song Lu,Ya-Ming Chang,Hung‐Li Wang	2014	48
6	XLID CUL4B mutants are defective in promoting TSC2 degradation and positively regulating mTOR signaling in neocortical neurons Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Hung‐Li Wang,Ning-Chun Chang,Yi‐Hsin Weng,Tu‐Hsueh Yeh	2013	15
7	Brain fluorodeoxyglucose positron emission tomography (¹⁸FDG PET) in patients with acute thallium intoxication Clinical Toxicology ·C. H. Liu,Kun‐Ju Lin,H. M. Wang,Hung‐Chou Kuo,Wu-Lung Chuang,Yi‐Hsin Weng,T.-S. Shih,Ching-Chun Huang	2013	2
8	H1152 promotes the degradation of polyglutamine-expanded ataxin-3 or ataxin-7 independently of its ROCK-inhibiting effect and ameliorates mutant ataxin-3-induced neurodegeneration in the SCA3 transgenic mouse Neuropharmacology ·Hung‐Li Wang,Su-Huei Hu,An-Hsun Chou,Shang-Seng Wang,Yi‐Hsin Weng,Tu‐Hsueh Yeh	2013	32
9	Quantitative analysis of binding sites for 9‐fluoropropyl‐(+)‐dihydrotetrabenazine ([¹⁸F]AV‐133) in a MPTP‐lesioned PD mouse model Synapse ·Ko‐Ting Chao,Hsin‐Hsin Tsao,Yi‐Hsin Weng,Ing‐Tsung Hsiao,Chia‐Ju Hsieh,Shiaw‐Pyng Wey,Tzu‐Chen Yen,Mei‐Ping Kung,Kun‐Ju Lin	2012	11
10	Genetic variants of SNCA and LRRK2 genes are associated with sporadic PD susceptibility: A replication study in a Taiwanese cohort Parkinsonism & Related Disorders ·Yah‐Huei Wu‐Chou,Ying‐Ting Chen,Tu‐Hsueh Yeh,Hsiu‐Chen Chang,Yi‐Hsin Weng,Szu‐Chia Lai,Chia-Ling Huang,Rou-Shayn Chen,Ying‐Zu Huang,Chiung-Chu Chen,June Hung,Wen-Li Chuang,Wey-Yil Lin,Chien‐Hsiun Chen,Chin-Song Lu	2012	34
11	PARK6 PINK1 mutants are defective in maintaining mitochondrial membrane potential and inhibiting ROS formation of substantia nigra dopaminergic neurons Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Hung‐Li Wang,An-Hsun Chou,Ai-Shun Wu,Si-Ying Chen,Yi‐Hsin Weng,Yu-Cheng Kao,Tu‐Hsueh Yeh,Po-Ju Chu,Chin-Song Lu	2011	103
12	PLA2G6 mutations in PARK14‐linked young‐onset parkinsonism and sporadic Parkinson's disease American Journal of Medical Genetics Part B Neuropsychiatric Genetics ·Chin‐Song Lu,Szu‐Chia Lai,Ruey‐Meei Wu,Yi‐Hsin Weng,Chia‐Ling Huang,Rou‐Shayn Chen,Hsiu‐Chen Chang,Yah‐Huei Wu‐Chou,Tu‐Hsueh Yeh	2011	62
13	High frequency of multiexonic deletion of the GCH1 gene in a Taiwanese cohort of dopa‐response dystonia American Journal of Medical Genetics Part B Neuropsychiatric Genetics ·Yah‐Huei Wu‐Chou,Tu‐Hsueh Yeh,Chuanyu Wang,Juei‐Jueng Lin,Chin‐Chang Huang,Hsiu‐Chen Chang,Szu‐Chia Lai,Rou‐Shayn Chen,Yi‐Hsin Weng,Chia‐Ling Huang,Chin‐Song Lu	2010	15
14	Impact of a nationwide outreach program on the diffusion of evidence-based practice in Taiwan International Journal for Quality in Health Care ·Ya Wen Chiu,Yi‐Hsin Weng,H. L. Lo,Ya-Hui Shih,C.-C. Hsu,Ken N. Kuo	2010	19
15	HDAC inhibitor sodium butyrate reverses transcriptional downregulation and ameliorates ataxic symptoms in a transgenic mouse model of SCA3 Neurobiology of Disease ·An-Hsun Chou,Si-Ying Chen,Tu‐Hsueh Yeh,Yi‐Hsin Weng,Hung‐Li Wang	2010	83
16	Analysis of the UCHL1 genetic variant in Parkinson's disease among Chinese Neurobiology of Aging ·Eng‐King Tan,Chin-Song Lu,Rong Peng,Yik Ying Teo,Yah-Huei Wu-Chou,R.‐S. Chen,Yi‐Hsin Weng,C.M. Chen,Hon‐Chung Fung,Louis C.S. Tan,Z.J. Zhang,Xingkai An,G.-J. Lee-Chen,M.C. Lee,Stephanie Fook‐Chong,Jean‐Marc Burgunder,Ruey‐Meei Wu,Yih‐Ru Wu	2009	14
17	The LRRK2 Arg1628Pro variant is a risk factor for Parkinson’s disease in the Chinese population Neurogenetics ·Chin-Song Lu,Yah‐Huei Wu‐Chou,Marina van Doeselaar,Erik Simons,Hsiu‐Chen Chang,Guido J. Breedveld,Alessio Di Fonzo,Rou-Shayn Chen,Yi‐Hsin Weng,Szu‐Chia Lai,Ben A. Oostra,Vincenzo Bonifati	2008	50
18	Analysis of the LRRK2 Gly2385Arg variant in primary dystonia and multiple system atrophy in Taiwan Parkinsonism & Related Disorders ·Chin‐Song Lu,Hsiu-Chen Chang,Yi‐Hsin Weng,Rou‐Shayn Chen,Vincenzo Bonifati,Yah-Huei Wu-Chou	2008	8
19	A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson’s disease risk in Taiwan Neurogenetics ·Alessio Di Fonzo,Yah‐Huei Wu‐Chou,Chin-Song Lu,Marina van Doeselaar,Erik Simons,Christan F. Rohé,Hsiu‐Chen Chang,Rou-Shayn Chen,Yi‐Hsin Weng,Nicola Vanacore,Guido J. Breedveld,Ben A. Oostra,Vincenzo Bonifati	2006	180
20	Pallidotomy effect on the cortical excitability in patients with severe Parkinson's disease Movement Disorders ·Chon‐Haw Tsai,Fang‐Chia Chang,Chin‐Song Lu,Shih‐Tseng Lee,Yuting Huang,Ming‐Kuei Lu,Rou‐Shayn Chen,Tony Wu,J. D. Lee,Yi‐Hsin Weng,Hsiu‐Chen Chang	2004	6

About Yi‐Hsin Weng

Yi‐Hsin Weng is a scholar working on Neurology, Neurology and Cellular and Molecular Neuroscience, having authored 33 papers that have together received 1.0k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (21 papers), Neurological diseases and metabolism (9 papers), Genetic Neurodegenerative Diseases (7 papers), Nuclear Receptors and Signaling (7 papers), Neurological disorders and treatments (6 papers), Ubiquitin and proteasome pathways (4 papers), Mitochondrial Function and Pathology (3 papers) and RNA regulation and disease (3 papers). The work is most often cited by research in Neurology (632 citations), Neurology (318 citations) and Cellular and Molecular Neuroscience (335 citations). Yi‐Hsin Weng has collaborated with scholars based in Taiwan, Netherlands and United Kingdom. Frequent co-authors include Tu‐Hsueh Yeh, Chin-Song Lu, Hung‐Li Wang, An-Hsun Chou, Rou-Shayn Chen, Yah‐Huei Wu‐Chou, Hsiu‐Chen Chang, Szu‐Chia Lai, Vincenzo Bonifati and Ying‐Ling Chen. Their work appears in journals such as The Journal of Physiology, International Journal of Molecular Sciences and Biochemical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact